You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

SARS-CoV-2 Test Information


Cepheid is expanding its Oncology portfolio to deliver life-changing technology to physicians and their cancer patients globally. We also offer a rapid test that detects the genetic risk for thrombosis.


Xpert® BCR-ABL Ultra

Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)

Learn More

Xpert® Bladder Cancer Detection

Detection of the presence of bladder cancer in patients with hematuria in 90 minutes 

Learn More

Xpert® Bladder Cancer Monitor

Qualitative monitoring for recurrence in patients previously diagnosed with bladder cancer in 90 minutes

Learn More

Xpert® Breast Cancer STRAT4

Semi-quantitative measurement of ESR1, PGR, ERBB2, and MKi67 from FFPE invasive breast cancer tissue in 2 hours

Learn More

Xpert® FII & FV

30 Minute test for genetic risk of Thrombosis

Learn More

CE-IVD. In Vitro Diagnostic Medical Device. Not available in all countries.
Back to Top